MYX 0.00% $4.40 mayne pharma group limited

Ann: MYX signs license agreement for women's health products, page-99

  1. 161 Posts.
    lightbulb Created with Sketch. 27
    Products are in growth phase..patents still in place till late 30s.. annovera launched just 2-3 years ago..

    TMD had cost issues..similar to Mayne for nextstellis. if Mayne can generate similar or higher revenue for TMD portfolio with incremental cost of $20m (which is what they have indicated), this will deliver around $30-$40m in EBITDA annualised.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.40
Change
0.000(0.00%)
Mkt cap ! $374.3M
Open High Low Value Volume
$4.42 $4.45 $4.23 $817.4K 187.9K

Buyers (Bids)

No. Vol. Price($)
1 164 $4.37
 

Sellers (Offers)

Price($) Vol. No.
$4.41 885 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.